China Alzheimer’s Disease Diagnostics Market (2025 - 2030) Size, Share & Trends Analysis Report By Diagnostic Technique (Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests), By Type (Triage, Diagnosis), By End-use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Procedure
                       1.2.2. End Use
                       1.2.3. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Procedure outlook
                       2.2.2. End Use outlook
                   2.3. Competitive Insights
Chapter 3. China Alzheimer’s Disease Diagnostics Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                       3.2.2. Market restraint analysis
                   3.3. China Alzheimer’s Disease Diagnostics Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
                   3.4. China Alzheimer’s Disease Diagnostics Market: Pipeline Analysis
Chapter 4. China Alzheimer’s Disease Diagnostics Market: Diagnostic Technique Estimates & Trend Analysis
                   4.1. Diagnostic Technique Segment Dashboard
                   4.2. China Alzheimer’s Disease Diagnostics Market: Diagnostic Technique Movement Analysis
                   4.3. China Alzheimer’s Disease Diagnostics Market Size & Trend Analysis, by Diagnostic Technique, 2018 to 2030 (USD Million)
                   4.4. Biomarkers
                       4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   4.5. Imaging Techniques
                       4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   4.6. Genetic Testing
                       4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   4.7. Cognitive Assessment Tests
                       4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. China Alzheimer’s Disease Diagnostics Market: Type Estimates & Trend Analysis
                   5.1. Type Segment Dashboard
                   5.2. China Alzheimer’s Disease Diagnostics Market: Type Movement Analysis
                   5.3. China Alzheimer’s Disease Diagnostics Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
                   5.4. Triage
                       5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   5.5. Diagnosis
                       5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   5.6. Screening
                       5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. China Alzheimer’s Disease Diagnostics Market: End Use Estimates & Trend Analysis
                   6.1. End Use Segment Dashboard
                   6.2. China Alzheimer’s Disease Diagnostics Market: End User Movement Analysis
                   6.3. China Alzheimer’s Disease Diagnostics Market Size & Trend Analysis, by End User, 2018 to 2030 (USD Million)
                   6.4. Hospitals
                       6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   6.5. Diagnostic Laboratories
                       6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   6.6. Academic and Research Institutes
                       6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                   7.1. Recent Developments & Impact Analysis, By Key Market Participants
                   7.2. Company/Competition Categorization
                   7.3. Vendor Landscape
                       1.3.1. Key company heat map analysis, 2024
                   7.4. Company Profiles
                       7.4.1. FujireBio
                           7.4.1.1. Company overview
                           7.4.1.2. Financial performance
                           7.4.1.3. Product benchmarking
                           7.4.1.4. Strategic initiatives
                       7.4.2. ALZpath
                           7.4.2.1. Company overview
                           7.4.2.2. Financial performance
                           7.4.2.3. Product benchmarking
                           7.4.2.4. Strategic initiatives
                       7.4.3. Quanterix
                           7.4.3.1. Company overview
                           7.4.3.2. Financial performance
                           7.4.3.3. Product benchmarking
                           7.4.3.4. Strategic initiatives
                       7.4.4. Hoffmann-La Roche
                           7.4.4.1. Company overview
                           7.4.4.2. Financial performance
                           7.4.4.3. Product benchmarking
                           7.4.4.4. Strategic initiatives
                       7.4.5. Life Molecular Imaging
                           7.4.5.1. Company overview
                           7.4.5.2. Financial performance
                           7.4.5.3. Product benchmarking
                           7.4.5.4. Strategic initiatives
                       7.4.6. Quest Diagnostics
                           7.4.6.1. Company overview
                           7.4.6.2. Financial performance
                           7.4.6.3. Product benchmarking
                           7.4.6.4. Strategic initiatives
                       7.4.7. Labcorp
                           7.4.7.1. Company overview
                           7.4.7.2. Financial performance
                           7.4.7.3. Product benchmarking
                           7.4.7.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 China Alzheimer’s disease diagnostics market, by diagnostic technique, 2018 - 2030 (USD Million)
Table 3 China Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 4 China Alzheimer’s disease diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 5 Financial performance
Table 6 Key companies undergoing expansions
Table 7 Key companies undergoing acquisitions
Table 8 Key companies undergoing collaborations
Table 9 Key companies launching new products/services
Table 10 Key companies undergoing partnerships
Table 11 Key companies undertaking other strategies

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 CHINA Alzheimer’s disease diagnostics market: market outlook
Fig. 10 Tumor ablation competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 China Alzheimer’s disease diagnostics market driver impact
Fig. 16 China Alzheimer’s disease diagnostics market restraint impact
Fig. 17 China Alzheimer’s disease diagnostics market strategic initiatives analysis
Fig. 18 China Alzheimer’s disease diagnostics market: Diagnostic technique movement analysis
Fig. 19 China Alzheimer’s disease diagnostics market: Diagnostic technique outlook and key takeaways
Fig. 20 Biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 CSF biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Blood-based biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Imaging techniques market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Generic testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Cognitive assessment tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 China Alzheimer’s disease diagnostics market: By type, movement analysis
Fig. 27 China Alzheimer’s disease diagnostics market: By Type outlook and key takeaways
Fig. 28 Triage market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Screening market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 China Alzheimer’s disease diagnostics market: End use, movement analysis
Fig. 32 China Alzheimer’s disease diagnostics market: End use outlook and key takeaways
Fig. 33 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Academic and research institutes market estimates and forecasts, 2018 - 2030 (USD Million)